For the Inventor, By the Inventor

Enter assignee name

Manchester, United Kingdom

Oxyrane UK Limited

USPTO Granted Patents = 16

% Expired Patents = 25.0

CIPO Patents = 3

EPO Patents = 9

Forward Citations = 104

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Wouter Vervecken (16 out of 18 patents)

Kathleen Camilla Telesphore Alida Maria Piens (8 out of 8 patents)

Steven Christian Jozef Geysens (7 out of 7 patents)

4. Nico Luc Marc Callewaert (7 out of 7 patents)

5. Karen Jacqueline Marcel De Pourcq (5 out of 5 patents)

6. Mouna Guerfal (5 out of 5 patents)

7. Gwenda Noëlla Pynaert (4 out of 4 patents)

8. Jan Robert Ludo Stout (2 out of 2 patents)

9. Han Karel Remaut (2 out of 11 patents)

10. Albena Vergilieva Valevska (2 out of 2 patents)

11. Petra Sophie Tiels (2 out of 3 patents)

12. Steven Geysens (1 out of 4 patents)

13. Stefan Simonne Prudent Eugène Christine Ryckaert (0 patent)

14. Kathleen Camilla Piens (0 patent)

15. Nico Luc Callewaert (0 patent)

16 patents: Sort by Forward Citations

1. 11225646 - Yeast strains producing mammalian-like complex n-glycans (2022-01-18),

2. 11040114 - Human alpha-N-acetylgalactosaminidase polypeptide (2021-06-22),

3. 10648044 - Methods and materials for treatment of Pompe's disease (2020-05-12),

4. 10392609 - Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose (2019-08-27),

5. 10344310 - De-mannosylation of phosphorylated N-glycans (2019-07-09),

6. 10287557 - Yeast strains producing mammalian-like complex N-glycans (2019-05-14),

7. 10023854 - Microorganisms genetically engineered to have modified N-glycosylation activity (2018-07-17),

8. 10011857 - Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins (2018-07-03),

9. 9689015 - De-mannosylation of phosphorylated N-glycans (2017-06-27),

10. 9598682 - Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose (2017-03-21),

11. 9347050 - Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins (2016-05-24),

12. 9249399 - Methods and materials for treatment of pompe's disease (2016-02-02),

13. 9222083 - Microorganisms genetically engineered to have modified N-glycosylation activity (2015-12-29),

14. 9206408 - Microorganisms genetically engineered to have modified N-glycosylation activity (2015-12-08),

15. 8597906 - Glycosylation of molecules (2013-12-03),

Company Overview

Oxyrane UK Limited is a technology-focused company based in Manchester, specializing in advanced materials and innovative solutions for various industries. The organization is dedicated to developing cutting-edge technologies that enhance product performance and sustainability. With a strong emphasis on research and development, Oxyrane operates in sectors such as energy, healthcare, and manufacturing, aiming to deliver high-quality, efficient solutions that meet the evolving needs of its clients and contribute to a more sustainable future.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#20 in Manchester

#1,118 in United Kingdom

#37,868 in the World

Manchester, United Kingdom

Oxyrane UK Limited

Forward Citations = 104

12 inventors:

Wouter Vervecken (16 out of 18 patents)

Kathleen Camilla Telesphore Alida Maria Piens (8 out of 8 patents)

Steven Christian Jozef Geysens (7 out of 7 patents)

4. Nico Luc Marc Callewaert (7 out of 7 patents)

5. Karen Jacqueline Marcel De Pourcq (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oxyrane UK Limited. Retrieved from https://idiyas.com/company/oxyrane-uk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…